Shared more. Cited more. Safe forever.
    • advanced search
    • submit works
    • about
    • help
    • contact us
    • login
    View Item 
    •   MOspace Home
    • University of Missouri-Columbia
    • College of Agriculture, Food and Natural Resources (MU)
    • Division of Applied Social Sciences (MU)
    • Department of Agricultural Economics (MU)
    • Economics and Management of Agrobiotechnology Center (MU)
    • AgBioForum (Journal)
    • AgBioForum, vol. 09, no. 2 (2006)
    • View Item
    •   MOspace Home
    • University of Missouri-Columbia
    • College of Agriculture, Food and Natural Resources (MU)
    • Division of Applied Social Sciences (MU)
    • Department of Agricultural Economics (MU)
    • Economics and Management of Agrobiotechnology Center (MU)
    • AgBioForum (Journal)
    • AgBioForum, vol. 09, no. 2 (2006)
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    advanced searchsubmit worksabouthelpcontact us

    Browse

    All of MOspaceCommunities & CollectionsDate IssuedAuthor/ContributorTitleIdentifierThesis DepartmentThesis AdvisorThesis SemesterThis CollectionDate IssuedAuthor/ContributorTitleIdentifierThesis DepartmentThesis AdvisorThesis Semester

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular AuthorsStatistics by Referrer

    Public Perceptions of Tobacco Biopharming

    Reaves, Dixie W.
    Norton, George W.
    Nevitt, Jonathan
    Mills, Bradford F.
    View/Open
    [PDF] Public perceptions of tobacco biopharming.pdf (206.5Kb)
    Date
    2006
    Format
    Article
    Metadata
    [+] Show full item record
    Abstract
    A telephone survey of United States consumers' views on tobacco biopharming indicates widespread support for developing the technology when it generates a socially beneficial application. Perceptions of risks associated with the technology, however, are split: Most respondents either hold concerns in every risk area presented or in none of them. Willingness to purchase a bio-tobacco-based medicine is bimodal as well. These polarized perceptions point to the challenges faced by policy makers who attempt to implement regulatory oversight of biopharming by balancing the broad-based concerns of the public against the potentially significant benefits of the technology.
    URI
    http://hdl.handle.net/10355/87
    Citation
    AgBioForum, 9(2) 2006: 104-110.
    Rights
    OpenAccess.
    This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.
    Collections
    • AgBioForum, vol. 09, no. 2 (2006)

    Send Feedback
    hosted by University of Missouri Library Systems
     

     


    Send Feedback
    hosted by University of Missouri Library Systems